HomeNDC LookupRxCUI directory › RxCUI 1660004

Thiotepa 100 MG Injection — RxCUI 1660004

RxNorm drug concept · Semantic clinical drug
RxCUI 1660004 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 13 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1660004
Official nameThiotepa 100 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asTSPA 100 MG Injection
FDA products mapped13
Package NDCs mapped13
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Thiotepa Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Thiotepa is a chemotherapy drug used for a few different conditions. It treats certain breast and ovarian cancers, helps control cancer-related fluid buildup in body cavities, and...
  • No, thiotepa is never taken at home. It's always given by a trained healthcare team in a hospital or clinic. Depending on what it's treating, it may be infused into a vein (intrave...
  • How will I receive thiotepa — do I take it at home?
  • Some side effects are very common — especially low blood counts, which can make you feel tired and more prone to infection. You may also experience mouth sores, nausea, diarrhea, a...
📖 Read our full Thiotepa Injection guide →

🕸️ Concept Web — How Thiotepa 100 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Thiotepa 100 MG Injection RxCUI 1660004

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Thiotepa 10473
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tepadina 1366537
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Thiotepa Injection 1660003
    • Thiotepa Injectable Product 1156487
    • Thiotepa Injection [Tepadina] 1919207
    • Tepadina Injectable Product 1919208
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Thiotepa 100 MG SCDC · 1660002
  • Thiotepa Injection SCDF · 1660003
  • Thiotepa Injectable Product SCDG · 1156487

Brand-Name Concepts

  • Thiotepa 100 MG Injection [Tepadina] SBD · 1919209
  • Thiotepa 100 MG [Tepadina] SBDC · 1919206
  • Thiotepa Injection [Tepadina] SBDF · 1919207
  • Tepadina Injectable Product SBDG · 1919208
  • Tepadina BN · 1366537

📦 FDA Products & Package NDCs

13 products · 13 package NDCs
13 package NDCs map to RxCUI 1660004 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9292-01 1 VIAL in 1 BOX, UNIT-DOSE (0143-9292-01) / 1 INJECTION, PO... Thiotepa Hikma Pharmaceuticals USA Inc. 2023-09-29
43598-0171-11 1 VIAL in 1 CARTON (43598-171-11) / 1 INJECTION, POWDER, LY... Thiotepa Dr.Reddy's Laboratories Inc., 2022-11-01
65219-0029-20 1 VIAL in 1 CARTON (65219-029-20) / 1 INJECTION, POWDER, LY... Thiotepa Fresenius Kabi USA, LLC 2022-04-11
68083-0446-01 1 VIAL in 1 CARTON (68083-446-01) / 1 INJECTION, POWDER, LY... Thiotepa Gland Pharma Limited 2021-03-08
68083-0503-01 1 VIAL in 1 CARTON (68083-503-01) / 1 INJECTION, POWDER, LY... Thiotepa Gland Pharma Limited 2022-01-03
70121-1630-01 1 VIAL, GLASS in 1 BOX (70121-1630-1) / 1 INJECTION, POWDER... TEPADINA Amneal Pharmaceuticals LLC 2017-08-15
70121-1631-01 1 VIAL, GLASS in 1 BOX (70121-1631-1) / 1 INJECTION, POWDER... TEPADINA Amneal Pharmaceuticals LLC 2017-08-15
70121-1687-01 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 BOX (701... TEPADINA Amneal Pharmaceuticals LLC 2025-04-18
70121-2749-01 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 BOX (701... TEPADINA Amneal Pharmaceuticals LLC 2025-04-18
71288-0156-05 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-156-05) / 1 INJECTIO... Thiotepa Meitheal Pharmaceuticals Inc 2023-12-26
71288-0157-10 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-157-10) / 1 INJECTIO... Thiotepa Meitheal Pharmaceuticals Inc 2023-12-26
72205-0045-01 1 VIAL, GLASS in 1 BOX (72205-045-01) / 1 INJECTION, POWDER... Thiotepa Novadoz Pharmaceuticals LLC 2020-02-01
72205-0046-01 1 VIAL, GLASS in 1 BOX (72205-046-01) / 1 INJECTION, POWDER... Thiotepa Novadoz Pharmaceuticals LLC 2020-02-01
Observed labelers: Amneal Pharmaceuticals LLC (4) · Gland Pharma Limited (2) · Meitheal Pharmaceuticals Inc (2) · Novadoz Pharmaceuticals LLC (2) · Dr.Reddy's Laboratories Inc., (1) · Fresenius Kabi USA, LLC (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9342 Inj thiotepa nos 1 mg 10 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.